+91 780-304-0404

Indian Infertility Diagnosis and Treatment Market

Indian Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Female Infertility Diagnosis (Ovulation Testing, Hysterosalpingography, Hysteroscopy, Imaging Testing, Ovarian Reserve Testing, Hormonal Level Testing, Genetic Testing, and Others), by Male Infertility Diagnosis (Semen Analysis, Genetic Testing, Testicular Biopsy, Hormone Testing, and Others), and by Infertility Treatment (Drugs and Medicine, Surgical Interventions, Assisted Reproductive Technology (ART), and Others) Forecast Period (2024-2031)

Published: Jul 2024 | Report Code: OMR2017108 | Category : Biotechnology | Delivery Format: /
Indian infertility diagnosis and treatment market is anticipated to grow at a CAGR of 12.5% during the forecast period (2024-2031).  India's rising infertility rates are influenced by factors such as delayed marriages, obesity, diabetes, and thyroid disorders. Lifestyle changes, technological advancements, and greater awareness of infertility treatments play a major role in promoting the Indian infertility diagnosis and treatment market. The modernization of healthcare facilities, partnerships with international fertility centers, and progress in genetic testing are improving access to advanced treatments, thereby boosting the market.
 
indian infertility diagnosis and treatment market dynamics

Market Dynamics

Increasing Infertility Rates

India is experiencing an increase in infertility rates as a result of health problems such as obesity, diabetes, and thyroid diseases in addition to delayed marriages and pregnancies. According to the World Health Organization, in July 2023, in India, this number escalated to approximately 15 to 20 million couples, which accounts for around 25.0% of infertility cases. Developing countries, including India, face a considerable challenge, with reports indicating that 1 in every 4 couples in such regions experiences infertility.

Increasing Medical Tourism Growth

India's medical tourism sector is growing rapidly owing to the country's accessible and superior medical services, especially in infertility diagnosis and treatment, that generate a significant number of international patients. According to the India Brand Equity Foundation (IBEF), in May 2024, the Indian medical tourism market was valued at US$ 7.69 billion in 2024 and is projected to reach US$ 14.31 billion by 2029, with 634,561 foreign tourists seeking medical treatment in India in 2023, representing 6.87% of total tourists. Ranked tenth in the Medical Tourism Index (MTI) for 2020-21 by the Medical Tourism Association, the Indian healthcare industry achieved a value of $372.0 billion in 2022. The e-health market is expected to reach $10.6 billion by 2025, while the Indian hospital sector was valued at $95.9 billion in FY21, employing 7.5 million people as of 2024.

Advancements in Medical Technology

Medical technology advancements, including ICSI (Intracytoplasmic Sperm Injection), PGD (Preimplantation Genetic Diagnosis), and time-lapse imaging, have led to innovative treatments and improved success rates in infertility treatments that propels the market growth. For instance, in August 2021, Merck Specialties Pvt Ltd launched the Pergoveris Pen for advanced infertility treatment in India. The pen provides a convenient, ready-to-use combination treatment option for women with severe follicle-stimulating hormone (FSH) and luteinizing hormone (LH) deficiency. Infertility is an endemic issue in India, requiring proper ovulation cycles. The Pen allows for improved treatment upon prescription by an IVF specialist.

Market Segmentation

  • Based on female infertility diagnosis, the market is segmented into ovulation testing, hysterosalpingography, hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, and others (thyroid function tests).
  • Based on male infertility diagnosis, the market is segmented into semen analysis, genetic testing, testicular biopsy, hormone testing, and others (imaging techniques, and anti-sperm antibody testing).
  • Based on infertility treatment, the market is segmented into drugs and medicine, surgical interventions, assisted reproductive technology (ART), and others (advanced reproductive technologies, and surrogacy).

Assisted Reproductive Technology (ART) Sub-segment to Hold a Considerable Market Share

The demand for ART is increasing owing to the increasing program awareness and acceptance among couples experiencing infertility. For instance, in February 2023, ART Fertility Clinics in India launched the "Tree of Life" program, planting a fruit-bearing tree sapling for every child born after treatment. Collaborated with SankalpTaru, the clinic planted over 150 saplings, celebrating new life and promoting sustainability and biodiversity.

Genetic Testing Sub-Segment To Hold a Considerable Market Share

Increased awareness and acceptance of infertility and treatment options, coupled with reduced stigma, are driving more couples to seek help propels the market growth. For instance, in December 2023, Progenesis opened a genetic testing lab in New Delhi and an AI & Bioinformatics Data Centre in Chennai, aiming to raise awareness about genetic diseases in India and simplify the preimplantation genetic testing process.?

Market Players Outlook

indian infertility diagnosis and treatment market players outlook
 
*Note: Major Players Sorted in No Particular Order.

The major companies serving the Indian infertility diagnosis and treatment market are Dr. Reddy’s Laboratories Ltd., Lupin Ltd., Sun Pharmaceutical Industries Ltd., Cipla Ltd., and Intas Pharmaceuticals Ltd., among others. The market players are focusing on capitalizing on growth by adopting strategies such as collaboration, partnerships, and market expansion among others. For instance, in May 2024, Birla Fertility & IVF expanded its South Indian market by acquiring ARMC IVF Fertility Centre, adding 7 new centers such as Kerala, Karnataka, and Tamil Nadu, to its network of 30 centers across 15 Indian states.

The Report Covers-

  • Market value data analysis of 2023 and forecast to 2031.
  • Annualized market revenues ($ million) for each market segment.
  • Key companies operating in the global Indian infertility diagnosis and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Industry Trends

2.2.2. Recommendations

2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis

3.2. Dr. Reddy’s Laboratories, Ltd.

3.2.1. Overview

3.2.2. Financial Analysis 

3.2.3. SWOT Analysis

3.2.4. Recent Developments

3.3. Lupin, Ltd.

3.3.1. Overview

3.3.2. Financial Analysis 

3.3.3. SWOT Analysis

3.3.4. Recent Developments

3.4. Sun Pharmaceutical Industries Ltd.

3.4.1. Overview

3.4.2. Financial Analysis 

3.4.3. SWOT Analysis

3.4.4. Recent Developments

3.5. Key Strategy Analysis

4. Market Segmentation

4.1. Indian Female Infertility Diagnosis Market by Diagnosis Type

4.1.1. Ovulation Testing 

4.1.2. Hysterosalpingography 

4.1.3. Hysteroscopy 

4.1.4. Imaging Testing 

4.1.5. Ovarian Reserve Testing 

4.1.6. Hormonal Level Testing 

4.1.7. Genetic Testing 

4.1.8. Others (Thyroid Function Tests)

4.2. Indian Male Infertility Diagnosis Market by Diagnosis Type

4.2.1. Semen Analysis

4.2.2. Genetic Testing

4.2.3. Testicular Biopsy

4.2.4. Hormone Testing

4.2.5. Others (Imaging Techniques, and Antisperm Antibody Testing)

4.3. Indian Infertility Diagnosis and Treatment Market by Infertility Treatment

4.3.1. Drugs And Medicine

4.3.2. Surgical Interventions

4.3.3. Assisted Reproductive Technology (ART)

4.3.4. Others (Advanced Reproductive Technologies, and Surrogacy)

5. Company Profiles 

5.1. Adorefem app

5.2. Alkem Laboratories Ltd

5.3. Biocon Ltd.

5.4. BSVL 

5.5. Cadila Pharmaceuticals Ltd.

5.6. Cipla Ltd.

5.7. Crysta IVF

5.8. Dr. D Pharma

5.9. Dr. Reddy’s Laboratories Ltd.

5.10. Emcure Pharmaceuticals

5.11. Intas Pharmaceuticals Ltd.

5.12. Maksun Biotech Pvt. Ltd.

5.13. Mestra pharma Pvt Ltd.

5.14. Nova IVF Fertility Private Limited

5.15. Pfizer Ltd.

5.16. Serum Institute of India Pvt. Ltd.

5.17. Torrent Pharmaceuticals Ltd.

5.18. Wockhardt Ltd.

5.19. Zauba Technologies Pvt. Ltd.

1. Indian Female Infertility Diagnosis Market Research And Analysis By Diagnosis Type, 2023-2031 ($ Million)

2. Indian Male Infertility Diagnosis Market Research And Analysis By Diagnosis Type, 2023-2031 ($ Million)

3. Indian Infertility Treatment Market Research And Analysis By Treatment Type, 2023-2031 ($ Million)

4. Dr. Reddy’s Laboratories, Ltd Financial Analysis, 2022 VS 2023 ($ Million)

5. Lupin, Ltd. Financial Analysis, 2022 VS 2023 ($ Million)

6. Sun Pharmaceutical Industries Ltd. Financial Analysis, 2022 VS 2023 ($ Million)

1. Indian Female Infertility Diagnosis Market Share By Diagnosis Type, 2023 Vs 2031 (%)

2. Indian Male Infertility Diagnosis Market Share By Diagnosis Type, 2023 Vs 2031 (%)

3. Indian Infertility Treatment Market Share By Treatment Type, 2023 Vs 2031 (%)

4. Indian Ovulation Testing For Female Infertility Diagnosis Market Size, 2023-2031 ($ Million)

5. Indian Hysterosalpingography For Female Infertility Diagnosis Market Size, 2023-2031 ($ Million)

6. Indian Hysteroscopy For Female Infertility Diagnosis Market Size, 2023-2031 ($ Million)

7. Indian Imaging Testing For Female Infertility Diagnosis Market Size, 2023-2031 ($ Million)

8. Indian Ovarian Reserve Testing For Female Infertility Diagnosis Market Size, 2023-2031 ($ Million)

9. Indian Hormonal Level Testing For Female Infertility Diagnosis Market Size, 2023-2031 ($ Million)

10. Indian Genetic Testing For Female Infertility Diagnosis Market Size, 2023-2031 ($ Million)

11. Indian Other Female Infertility Diagnosis Market Size, 2023-2031 ($ Million)

12. Indian Infertility Diagnosis and Treatment Market Research And Analysis By Male Infertility Diagnosis, 2023-2031 ($ Million)

13. Indian Semen Analysis For Male Infertility Diagnosis Market Size, 2023-2031 ($ Million)

14. Indian Genetic Testing For Male Infertility Diagnosis Market Size, 2023-2031 ($ Million)

15. Indian Testicular Biopsy For Male Infertility Diagnosis Market Size, 2023-2031 ($ Million)

16. Indian Hormone Testing For Male Infertility Diagnosis Market Size, 2023-2031 ($ Million)

17. Indian Others Male Infertility Diagnosis Market Size, 2023-2031 ($ Million)

18. Indian Infertility Diagnosis and Treatment Market Research And Analysis By Infertility Treatment, 2023-2031 ($ Million)

19. Indian Drugs And Medicine For Infertility Treatment Market Size, 2023-2031 ($ Million)

20. Indian Surgical Interventions For Infertility Treatment Market Size, 2023-2031 ($ Million)

21. Indian Assisted Reproductive Technology (ART) For Infertility Treatment Market Size, 2023-2031 ($ Million)

22. Indian Other Infertility Treatment Market Size, 2023-2031 ($ Million)

Choose License Type
    On Discount

100%
Secured Payment

Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report
Related Reports